Generic Viagra As A Contender

While Pfizer, one of the largest pharmaceutical manufacturing sources in the world, challenges copycat makers of generic Viagra, the reality is that there are always scientists, inventors, and engineers working on reinventing the wheel…or on refining medications and treatments such as generic Viagra—making such a recreation more affordable and more accessible. For example, the Pharmacological Institute in Warsaw has found a way to simulate by synthesizing sildenafil citrate, making a new generic Viagra, which has been taken by Polpharma, a pharmaceutical manufacturer in Poland, for production. Working with the biotechnology company, Icos Corporation, in Bothell, Washington, Eli Lily has developed Cialis, another cheaper but evidently no less effective generic Viagra. While it has not reportedly been significantly studied in comparison to Viagra, Cialis has passed a number of tests indicating fewer side effects than Viagra, as well, and indicating a half-life (lasting time) of not four hours but 24 hours. Bayer AG has also created a generic Viagra, one that has yet to be named as anything other than its major chemical component—vardenafil—thus far. The drug has undergone testing and has been found to have a better track record for some

men, working every time as opposed to sometimes working and sometimes having no effect on erectile dysfunction at all. But generic Viagra still has to contend with its founding father, Viagra. The tests done as follow-up on patient satisfaction are repeatedly positive: studies of long-term users of the medication, for instance, boast reports of hundreds of men over the age of 55 having perpetual erectile dysfunction, using Viagra for one to two years, and being exceptionally satisfied every single time. So while it sometimes helps immensely to purchase a cheaper version, a simulation, an imitation, it also still holds true that the real thing can many times produce the best results.